跳至主要内容
临床试验/NCT02262156
NCT02262156已完成不适用

Treatment Of Depression In Patients With Temporal Lobe Epilepsy: Comparative Study Of Cognitive Behavioral Therapy Vs. Selective Serotonin Reuptake Inhibitors

El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
1
主要终点
Change in Beck Depression Inventory score

研究概览

简要总结

The aim of the study is to compare the effect of group-cognitive-behavioral therapy (CBT)versus treatment as usual with the selective serotonin reuptake inhibitor sertraline, in patients with diagnosis of temporal lobe epilepsy (TLE) and depressive disorder.

详细描述

patients with temporal lobe epilepsy and depression will be enrolled into one of two treatment modality. The first group will receive 12 group cognitive behavioral sessions. CBT is a psychotherapy focused on the recognition and change of distorted thoughts and maladaptive behaviors.

The second group will receive treatment with the selective serotonin reuptake inhibitor sertraline or citalopram for 12 weeks. This antidepressant is wide used to treat depression in patients with TLE.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • With Major depressive disorder according to criteria from the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
  • Diagnosed with TLE according to the criteria of the International League Against Epilepsy
  • Literates had sign an informed consent
  • Patients on antidepressant treatments will be allowed to participate only if they had been at stable doses for more than 8 weeks and still show signs of significant depression

排除标准

  • Patients with high risk of suicide who required hospitalization
  • Patients who abused or are dependent on drugs
  • Those with a history of head trauma six months prior to the interview
  • Patients who have any condition that would prevent them from understanding the study or the psychotherapeutic process, such as mental retardation, psychosis, delirium, dementia, etc
  • Patients who have previously received CBT
  • Patients who have started, an antidepressant drug the last 8 weeks

研究组 & 干预措施

Cognitive behavioral Therapy

Experimental

CBT program to be used in group modality that focused on managing symptoms of depression in patients with epilepsy.

12 CBT sessions, consisting of one weekly 90-minute session for 12 consecutive weeks.

干预措施: Cognitive behavioral therapy (Other)

Selective serotonin euptake inhibitor

Active Comparator

Patients will receive a SSRI (sertraline or citalopram) for 12 weeks. Dose will be adjusted every 4 weeks according to medical criteria.

干预措施: SSRI (Drug)

结局指标

主要结局

Change in Beck Depression Inventory score

时间窗: baseline, 6 weeks and 12 weeks

次要结局

  • Quality of Life in Epilepsy Scale(baseline, 6 weeks and 12 weeks)
  • Hospital anxiety and depression scale (HADS)(baseline, 4weeks and 12 weeks)

研究者

发起方
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
申办方类型
Other
责任方
Principal Investigator
主要研究者

Edgar Daniel Crail Melendez

Md

El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

研究点 (1)

Loading locations...

相似试验

CBT Versus Selective Serotonin Reuptake Inhibitor... | 临床试验